Palliative Medicine
Overall goal of palliative medicine
Relieve suffering and maximize quality of life for patients with a serious illness
First line treatment for pts with Dyslipidemia
Statins
Rebound Insomnia
First line for Moderate-Severe pain
Most commonly used illicit drug
Marijuana
6 months or less
Recommended diet for pts with elevated cholesterol
DASH
Diagnoses of SEID (Systemic Exertion Intolerance Disease)
Diagnoses of exclusion
Risk factors for chronic opioid use (2)
Dependence and Tolerance
3 most common stimulant drugs abused
Methamphetamines, cocaine, and substituted cathinones (bath salts)
4 common causes of constipation in palliative medicine
opioids, dehydration, immobility, metabolic disturbances
Screening age for lipid disease
40-75
Timelines for Acute, Subacute, and Chronic cough
<3 weeks, 3-8 weeks, and >8 weeks respectively
3 medications for Neuropathic pain
Gabapentin, pregabalin, and duloxetine
DSM-5 criteria for MDD
Depressed mood or anhedonia for 2 weeks (musk have 1)
With 4 other of : fatigue, insomnia, suicidal thoughts, decreased concentration, or weight loss
Most important factor in success of palliative intervention
Symptom management
Score needed to be calculated in pts with Dyslipidemia
10 year ASCVD risk score (AHA or ACC)
5 P's of arterial insufficiency
Pain, Pallor, Poikilothermia, Pulselessness, Paresthesia
Visceral or somatic Nociceptors
Definition of specific phobia
unreasonable fear for 6 months or longer
End of life anorexia and weight loss treatment
NONE (important to address reversible, if any, causes of anorexia and weight loss)
What are the 5 secondary causes of elevated LDL (4/5 acceptable for win)
Hypothyroidism, Poorly controlled Diabetes Mellitus, Nephrotic syndrome, and Medications (e.g., glucocorticoids, diuretics, amiodarone)
Name at least 4 causes of Peripheral Vertigo
BPPV, Vestibular Neuronitis, Labyrinthitis, Meniere disease, m=Medication effects (toxicity from aminoglycoside or diuretic use), Ramsay Hunt syndrome (herpes zoster involving cranial nerve VII), and Vestibular Schwannoma (acoustic neuroma).
Methadone MOA
Opioid agonist and NMDA receptor antagonist
DSM-5 diagnostic criteria for schizophrenia
2 of the following: delusions, hallucinations, disorganized speech, disorganized or catatonic behavior, and negative symptoms.
1 area of functional impairment (occupation, social interactions, or self-care)
Duration of at least 6 months, including 1 month of active symptoms.